76Bio, Inc. — Form D

76Bio, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-13. The offering totals $12.2M, of which $12.2M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-02-13
Form: D
Accession: 0001437749-23-003187
Industry: Biotechnology
Exemptions: 06b
Total offering: $12.2M
Amount sold: $12.2M
Investors: 32
Date of first sale: 2023-02-06
Revenue range: Decline to Disclose
SEC file number: 021-473359

Issuer

Name: 76Bio, Inc.
CIK: 0001903465
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 40 Guest Street, Boston, MA, 01235
Phone: 212-871-7920

Officers, directors & promoters (7)

Name	Role	Location
David M Tanen	Director	New York, NY
David M Tanen	Executive Officer	New York, NY
David M Tanen	Promoter	New York, NY
Christopher M Wilfong	Director	Boston, MA
Christopher M Wilfong	Executive Officer	Boston, MA
Christopher M Wilfong	Promoter	Boston, MA
Angela M Koehler	Director	Boston, MA

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2023-02-14	D/A	$12.2M	$12.2M
2022-01-10	D	$10.0M	$10.0M

More